RPRML

 

Full name: reprimo like Alias Symbol: MGC43894
Type: protein-coding gene Cytoband: 17q21.32
Entrez ID: 388394 HGNC ID: HGNC:32422 Ensembl Gene: ENSG00000179673 OMIM ID: 
Drug and gene relationship at DGIdb

 

Expression of RPRML:

 

Dataset Gene EntrezID Probe Log2FC Adj.pValue Expression
GSE17351 RPRML 388394 1554655_a_at -0.0673 0.7208
GSE26886 RPRML 388394 1554655_a_at 0.0242 0.9148
GSE45670 RPRML 388394 1554655_a_at -0.2582 0.0362
GSE53622 RPRML 388394 99192 0.1862 0.0092
GSE53624 RPRML 388394 99192 0.0990 0.4174
GSE63941 RPRML 388394 1554655_a_at 0.0472 0.8933
GSE77861 RPRML 388394 1554655_a_at -0.1201 0.5411
GSE97050 RPRML 388394 A_33_P3339138 0.1503 0.5746
TCGA RPRML 388394 RNAseq -1.9393 0.0222

Upregulated datasets: 0; Downregulated datasets: 1.  


 

Survival by RPRML expression:

 

GSE53622GSE53624TCGA

 

Note: Click image to view full size file.  


Copy number change of RPRML:

 

Dataset Gene EntrezID Gain Loss Normal Detail
GSE15526 RPRML 388394 5 2 23
GSE20123 RPRML 388394 5 2 23
GSE43470 RPRML 388394 1 2 40
GSE46452 RPRML 388394 32 0 27
GSE47630 RPRML 388394 9 0 31
GSE54993 RPRML 388394 2 4 64
GSE54994 RPRML 388394 11 5 37
GSE60625 RPRML 388394 4 0 7
GSE74703 RPRML 388394 1 1 34
GSE74704 RPRML 388394 4 1 15
TCGA RPRML 388394 26 6 64

Total number of gains: 100; Total number of losses: 23; Total Number of normals: 365.  


 

Somatic mutations of RPRML:

 

Generating mutation plots.

 

Highly correlated genes for RPRML:

 

Showing top 20/226 corelated genes with mean PCC>0.5.
Gene1 Gene2 Mean PCC Num. Datasets Num. PCC<0 Num. PCC>0.5
RPRMLSLC32A10.774725303
RPRMLDAOA0.763084303
RPRMLAK10.681363303
RPRMLHRH20.680069303
RPRMLCRYBB10.678916404
RPRMLOR11A10.676133303
RPRMLLCE1D0.675902303
RPRMLGNAT10.67526303
RPRMLCHMP60.674693303
RPRMLCPLX30.673076303
RPRMLCATSPERG0.668092303
RPRMLKRTAP10-30.666868303
RPRMLOR3A20.663793404
RPRMLRPGRIP1L0.662218303
RPRMLRSPH90.659043303
RPRMLFAM71E10.658673303
RPRMLFAM131C0.658243504
RPRMLBRF10.655827504
RPRMLLINC013520.65318303
RPRMLELFN10.652103403

For details and further investigation, click here